The Respiratory Department at NBT has implemented Triage Services (RAS) for respiratory referrals. Referrals made by eRS to NBT will be triaged and directed to the most appropriate service or returned to GPs with advice.
Prior to referral:
If CXR shows unilateral pleural effusion then refer to the Pleural Clinic Triage Service - North Bristol Lung Centre - Southmead - RVJ
For patients with confirmed diagnosis of emphysema requiring consideration for lung volume reduction then refer to the Airways/COPD/Asthma Triage Service - North Bristol Lung Centre - Southmead/Cossham - RVJ
ALL other patients should be referred via the Respiratory Medicine Triage Service - North Bristol Lung Centre - Southmead/Cossham/Thornbury - RVJ
Refer
Referrals should be submitted via e-referral requesting the appropriate RAS service as above.
Priority - Routine & Urgent
Specialty - Respiratory Medicine
Clinic Type - Triage service as above
Once the referrals have been assessed, the centralised booking team will contact the patient and agree an appointment over the phone. If they are unable to contact them after 3 attempts (over several days), an appointment will be allocated for them. The patient will retain the ability to reschedule their appointment, which they can do by contacting the outpatients department on 0300 555 0103.
Refer via the BRI Triage Service options (above) who will triage and divert internally to WGH.
Refer
Referrals should be submitted via e-referral requesting the appropriate Triage service as above.
Priority - Routine & Urgent
Specialty - Respiratory Medicine
Clinic Type - Triage service as above
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.